View Older Stories View More Recent Stories

Feb 1, 2024 09:00AM Be Biopharma to Present at the 20th Annual WORLDSymposium™ 2024
Jan 31, 2024 08:00AM MBX Biosciences to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
Jan 30, 2024 05:04PM Investors and Innovators Representing more than $309B in Biotech Assets and 624 New Drugs in Development Urge the Congressional Budget Office to Update its Drug R&D Policy Impact Model
Jan 30, 2024 05:04PM Investors and Innovators Representing more than $309B in Biotech Assets and 624 New Drugs in Development Urge the Congressional Budget Office to Update its Drug R&D Policy Impact Model
Jan 30, 2024 09:08AM Astria Therapeutics (ATXS) Prices 10.34M Share Offering at $12.09/sh
Jan 30, 2024 09:08AM Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
Jan 30, 2024 08:15AM Jnana Therapeutics Announces Positive Clinical Proof of Concept Achieved with JNT-517, a Potential First-in-Class Oral Treatment for PKU
Jan 29, 2024 04:31PM Form SC 13G Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 29, 2024 08:36AM New Company Eyconis Formed to Develop Ascendis Pharma (ASND) Ophthalmology Assets with $150 Million Commitment from External Investors
Jan 29, 2024 08:30AM New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets with $150 Million Commitment from External Investors
Jan 25, 2024 09:00AM Be Biopharma to Present at Keystone Symposia on Emerging Cellular Therapies
Jan 22, 2024 07:34AM Dianthus Therapeutics (DNTH) Announces $230 Million Private Placement of Common Stock, Warrants
Jan 22, 2024 07:30AM Dianthus Therapeutics Announces $230 Million Private Placement
Jan 19, 2024 04:31PM Form SC 13G Vaxart, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 19, 2024 08:38AM Edgewise Therapeutics (EWTX) Prices $240 Million Underwritten Offering of Common Stock
Jan 19, 2024 08:37AM Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock
Jan 17, 2024 08:05AM Day One Biopharmaceuticals (DAWN) Announces Two New Appointments to Board of Directors
Jan 17, 2024 08:00AM Day One Announces Two New Appointments to Board of Directors
Jan 16, 2024 09:25AM Vaxart (VXRT) Announces 15.38M Share Offering at $0.65/sh
Jan 16, 2024 09:25AM Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
Jan 12, 2024 05:01PM Form SC 13G Longboard Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 12, 2024 10:28AM San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry
Jan 11, 2024 05:25PM Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 10, 2024 02:30PM Commons Clinic Launches the Center for Spine Economics, Outcomes & Research to Pioneer Spinal Restoration Care Model
Jan 8, 2024 07:10AM Solid Biosciences (SLDB) Enters $108.9M Private Placement
Jan 8, 2024 07:09AM Solid Biosciences Announces $109 Million Private Placement
Jan 4, 2024 04:01PM Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization
Jan 4, 2024 08:00AM Jnana Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Jan 4, 2024 03:55AM GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry
Dec 29, 2023 04:31PM Form SC 13G UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 28, 2023 09:00AM Be Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Dec 26, 2023 04:30PM Form SC 13G C4 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 24, 2023 09:15PM FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy
Dec 20, 2023 04:30PM Form SC 13D/A Connect Biopharma Holdin Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 20, 2023 08:30AM Ocelot Bio Receives FDA Orphan Drug Designation for OCE-205 for the Treatment of Ascites
Dec 20, 2023 08:00AM MBX Biosciences to Participate in 42nd Annual J.P. Morgan Healthcare Conference
Dec 14, 2023 04:31PM Form SC 13D/A Connect Biopharma Holdin Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 14, 2023 09:00AM Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO
Dec 14, 2023 07:34AM Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations
Dec 13, 2023 04:30PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 12, 2023 08:00AM Aiolos Bio Strengthens and Expands Leadership Team with Key Appointments
Dec 10, 2023 12:30PM Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B​
Dec 7, 2023 06:25AM CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum
Dec 6, 2023 08:00AM Jnana Therapeutics to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference
Dec 4, 2023 05:21PM Form SC 13D/A Connect Biopharma Holdin Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 4, 2023 10:00AM AM Batteries Closes $30M Series B led by Toyota Ventures to Accelerate the Commercialization of its Dry Battery Electrode Technology
Nov 30, 2023 09:00AM Adela Presents Data Demonstrating Strong Prognostic Prediction Capabilities in Lung Cancer at the 2023 Multidisciplinary Thoracic Cancers Symposium
Nov 27, 2023 04:30PM Form SC 13G Third Harmonic Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 27, 2023 07:01AM Arvinas Inc. (ARVN) Announces Oversubscribed $350M Share and Warrant Placement at $21.36/sh
Nov 27, 2023 07:00AM Arvinas Announces Oversubscribed $350 Million Private Placement
View More Recent Stories View Older Stories